Genomtec (FRA:4VI) Moat Score: 0/10 (As of Jul. 08, 2026)


FRA:4VI Genomtec SA FRA:4VI
30 GF Score
Price €0.99
GF Value €0.41
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Genomtec Moat Score?

Genomtec has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Genomtec has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Genomtec might have No Moat - No discernible moat.

Genomtec  (FRA:4VI) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Genomtec Moat Score Related Terms

FRA:4VI
30GF Score
Genomtec SA FRA:4VI
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Genomtec (FRA:4VI) Overvalued in 2026?

Based on GuruFocus' analysis, Genomtec stock appears to be overvalued. The current stock price of €0.99 is trading 141.5% above its estimated GF Value™ of €0.41. GuruFocus considers Genomtec to be Significantly Overvalued.

Key valuation signals for FRA:4VI:

  • Moat Score: 0
  • GF Value™: €0.41 vs. price of €0.99 (141.5% above fair value)
  • GF Score™: 30/100 with 5 warning signs

No single metric tells the full story. See the FRA:4VI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genomtec Business Description

Other Exchanges GMT:Poland
Address ul. Stablowicka 147, PORT Building 2, Wroclaw, POL, 54-066
Genomtec SA is an technology company which works in the area of ?? molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.
30GF Score

Get the complete analysis for FRA:4VI

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.99
Price
€0.41
GF Value